Our goal is to provide the most effective, safe, and current methods available to treat our patients.  Standard treatments available are the end result of past clinical research.  New and safer, more efficacious medications may be approved as the result of ongoing studies.  We want to be involved in these processes, to be able to offer the latest therapies and explore new treatment options.
 
The employees of Signal Point Clinical Research Center will work together using the principles of Good Clinical Practice to conduct quality research.  The Code of Federal Regulations Part 21 will be our guiding document for all research activities.  Following these guidelines, we will be a valuable component in the development of improved treatment options for many medical conditions.